santa cruz biotechnology, inc.
SCBT Logo

Benvenuto!       Visualizza carrello     Quick Order

CA19-9 (241) Anticorpo: sc-59481

 |  Scheda tecnica
  • mouse monoclonal IgG1, 100µg/ml
  • raised against COLO 205 colorectal adenocarcinoma cell line of human origin
  • recommended for detection of CA19-9 (Sialyl Lewis a containing glycolipids) of human origin by IF and IHC(P); non cross-reactive with Lewis a, Lewis b or structurally related substances
 
Altri Blood Group Antigen Anticorpi ...
 
Informazioni ordini
Recommended Support Products:
(click button of application of choice)
IF   IHC(P)   siRNA  
Seleziona la valuta

 Informazioni ordini
Nome del prodottoCodice del prodottoUnitàPrezzoQuantitàAggiungiFavorites
CA19-9 (241) sc-59481 100 µg/ml $279

CA19-9 Background Information
Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens are usually mucin-type and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis a, Lewis b, Lewis x, Lewis y, CA19-9, and precursor type 1 chain antigens. CA19-9 is associated with colon pancreatic, and endometrial cancer as well as intestinal metaplasia.